Literature DB >> 16612394

Contrast-induced nephropathy: definition, epidemiology, and patients at risk.

R Mehran1, E Nikolsky.   

Abstract

Radiological procedures utilizing intravascular iodinated contrast media injections are being widely applied for both diagnostic and therapeutic purposes. This has resulted in an increasing incidence of procedure-related contrast-induced nephropathy (CIN). The definition of CIN includes absolute (> or = 0.5 mg/dl) or relative increase (> or = 25%) in serum creatinine at 48-72 h after exposure to a contrast agent compared to baseline serum creatinine values, when alternative explanations for renal impairment have been excluded. Although the risk of renal function impairment associated with radiological procedures is low (0.6-2.3%) in the general population, it may be very high in selected patient subsets (up to 20%), especially in patients with underlying cardiovascular disease. This review provides information on the known risk factors for the development of CIN, and completes with describing user-friendly CIN risk score based on the readily available information.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612394     DOI: 10.1038/sj.ki.5000368

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  196 in total

1.  Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn's disease.

Authors:  Caroline Kerner; Kathleen Carey; Angela M Mills; Wei Yang; Marie B Synnestvedt; Susan Hilton; Mark G Weiner; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-22       Impact factor: 11.382

2.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-08       Impact factor: 2.801

3.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Jpn J Radiol       Date:  2013-08       Impact factor: 2.374

Review 4.  Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.

Authors:  Wen-Qi Ma; Yu Zhao; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

5.  Reduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.

Authors:  Jeremiah R Brown; Michael E Rezaee; William M Hisey; Kevin C Cox; Michael E Matheny; Mark J Sarnak
Journal:  Am J Nephrol       Date:  2016-04-29       Impact factor: 3.754

6.  Urinary kidney injury molecule-1 as an early indicator to predict contrast-induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention.

Authors:  Wenhua Li; Yaren Yu; Haiyan He; Jing Chen; Debin Zhang
Journal:  Biomed Rep       Date:  2015-04-16

7.  Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter United States registry.

Authors:  Tesfaldet T Michael; Dimitri Karmpaliotis; Emmanouil S Brilakis; Mohammed Alomar; Shuaib M Abdullah; Ben L Kirkland; Katrina L Mishoe; Nicholas Lembo; Anna Kalynych; Harold Carlson; Subhash Banerjee; Michael Luna; William Lombardi; David E Kandzari
Journal:  Catheter Cardiovasc Interv       Date:  2014-01-31       Impact factor: 2.692

8.  Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.

Authors:  Terry E Jones; Hayley Vasileff; Cassie Hewton
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

9.  Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury.

Authors:  Ali Amiri; Reza Ghanavati; Hassan Riahi Beni; Seyyed Hashem Sezavar; Mehrdad Sheykhvatan; Mahsa Arab
Journal:  Cardiorenal Med       Date:  2018-06-15       Impact factor: 2.041

10.  High dose intracoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction.

Authors:  Markus Meyer; Stephen P Bell; Zengyi Chen; Iwan Nyotowidjojo; Richard R Lachapelle; Timothy F Christian; Pamela C Gibson; Friederike F Keating; Harold L Dauerman; Martin M LeWinter
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.